Typing of pneumococcal surface protein a (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: Towards novel pneumococcal protein vaccines

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 3890-3896

  Brandileone, Maria Cristina C ^a   Andrade, Ana Lucia S S ^b   Teles, Elaine M ^c   Zanella, Rosemeire C ^a   Yara, Teresa I ^a   Di Fabio, José Luis ^d   Hollingshead, Susan K ^e  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d PAN AMERICAN HEALTH ORGANIZATION   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

PspA; Streptococcus pneumoniae; Vaccine

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN ISOLATION; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; BACTERIAL PROTEINS; BLOTTING, WESTERN; BODY FLUIDS; BRAZIL; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; HUMANS; INFANT; MIDDLE AGED; NASOPHARYNX; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, SUBUNIT;

EID: 4544282640     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.009     Document Type: Article

References (31)

1. Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Rev. Infect. Dis. 14:1992;801-807
2. Baquero F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microb. Drug Resist. 1:1995;115-120
3. Paris M.M., Ramilo O., McCracken G.H. Jr. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:1995;2171-2175
4. Cowan M.J., Ammann A.J., Wara D.W., Howie V.M., Schultz L., Doyle N., et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics. 62:1978;721-727
5. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanent Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:2000;187-195
6. Brandileone M.C.C., Andrade A.L.S., Di Fabio J.L., Guerra M.L.L.S., Austrian R., et al. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J. Infect. Dis. 187:2003;1206-1212
7. Di Fabio J.L., Quadros C. Considerations for combination vaccine development and use in the developing world. Clin. Infect. Dis. 33(4):2001;340-345
8. Briles D.E., Hollingshead S., Brooks-Walter A., Nabors G.S., Ferguson L., Schilling M., et al. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine. 18:2000;1707-1711
9. Briles D.E., Hollingshead S.K., Nabors G.S., Paton J.C., Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine. 19:2001;S87-S95
10. Briles D., Ades E., Paton J.C., Sampson J.S., Carlone G.M., Huebner R.C., et al. Intranasal Immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68(2):2000;796-800
11. Paton J.C. Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol. 6:1998;85-88
12. Briles D.E., Tart R.C., Swiatlo E., Dillard J.P., Smith P., Benton K.A., et al. Pneumococcal diversity: considerations for new vaccine strategies with an emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:1998;645-657
13. Jedrzejas M. Pneumococcal virulence factores: struture and functions. Microbiol. Mol. Biol. Rev. 65(2):2001;187-207
14. McDaniel L.S., Scott G., Kearney J.F., Briles D.E. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160:1984;386-397
15. Ren B., Szalai A.J., Thomas O., Hollingshead S., Briles D.E. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect. Immun. 71(1):2003;75-85
16. Miyaji E.N., Ferreira D.M., Lopes A.P.Y., C M.C., Dias W.O., Leite L.C.C. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect. Immun. 70(9):2002;5086-5090
17. Nabors G.S., Braun P.A., Herrmann D., Heise M.L., Pyle D.J., Gravenstein S., et al. Immunization of health adults with a single recombinant pneumococcal surface protein (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine. 18:2000;1743-1754
18. McDaniel L.S., Sheffield J.S., Delucchi P., Briles D.E. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59:1991;222-228
19. McDaniel L.S., Ralph B.A., McDanial D.O., Briles D.E. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192-260. Microb. Pathog. 17:1994;323-337
20. Hollingshead S.K., Becker R., Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68(10):2000;5889-5900
21. Coral M.C.V., Fonseca N., Castañeda E., Di Fabio J.L., Holinsghead S., Briles D.E. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg. Infect. Dis. 7(5):2001;832-836
22. Kleinbaum DG, Kupper LL, Morgenstern H, Design options in observational studies. In: Kleinbaum DG, Kupper LL, Morgenstern H, editors. Epidemiologic research. Principles and quantitative methods. New York, Van Nostrand Reinhold; 1982. p. 51-61.
23. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard (M7-A6, vol. 23), 6th ed., National Committee for Clinical Laboratory Standards, Wayne, PA.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein Measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
25. Brandileone M.C.C., Di Fabio J.L., Vieira V.S.D., Zanella R.C., Casagrande S.T., Pignatari A.C., et al. Geographic distribution of penicillin resistance of Streptococcus pneumoniae in Brazil: genetic relatedness. Microb. Drug. Resist. 4:1998;209-217
26. Di Fabio J.L., Castañeda E., Agudelo C.I., De La Hoz F., Hortal M., Camou T., et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, SIREVA-Vigía Group, 1993 to 1999. Pediatr. Infect. Dis. J. 20:2001;959-967
27. McGee L., McDougal L., Zhou J., Spratt B.G., Tenover F.C., George R., et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J. Clin. Microbiol. 39:2001;2565-2571
28. Tomasz A, Corso A, Members of the PAHO/Rockefeller University Workshop. Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. Microb Drug Resist 1998;4:195-207.
29. Beall B., Gherardi G., Facklam R.R., Hollingshead S.K. Pneumococcal pspA sequence types of the prevalent multi-resistant pneumococcal strains in the United States and of internationally disseminated clones. J. Clin. Microbiol. 38:2000;3663-3669
30. Dicuonzo G., Gherardi G., Gertz R.E., D'Ambrosio F., Goglio A., Lorino G., et al. Genotypes of invasive pneumococcal isolates recently recoverd from Italian patients. J. Clin. Microbiol. 40(10):2002;3660-3665
31. Miyaji E.N., Dias W.O., Tanizaki M.M., Leite L.C. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccine contribution of both humoral and cellular immune response. FEMS Immunol. Med. Microbiol. 37(1):2003;53-57